Lona Biotherapeutics Ltd.
PrivateLast Round
Private Placement
Dec 18, 2025
Est. Valuation
$670M
Total Funding Raised
$104.4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Lona Biotherapeutics Ltd. is a biotechnology company that develops AI-guided, personalized TCR-T cell therapies for the treatment of blood cancers and solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lona Biotherapeutics Ltd. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Lona Biotherapeutics Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Dec 18, 2025 | ||||
| IPO Announced | Sep 17, 2020 | ||||
| Series B | Jun 4, 2020 | ||||
| Grant | Nov 15, 2018 | ||||
| VC Round | Nov 2, 2017 | ||||
Grant | Apr 13, 2017 |
Lona Biotherapeutics Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | Series B |
| Ligand Pharmaceuticals | Private Placement |
| Janus Henderson Group | Series B |
| TCG Crossover | Private Placement |
| LifeSci Venture Partners | Series B |
| Dolby Family Ventures | Series A, VC Round |
| Kayne Anderson Capital Advisors | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 18, 2025
$90M round led by Commodore Capital, Perceptive Advisors, and TCG Crossover.
- Feb 11, 2016
$10M round with Dolby Family Ventures and W Fund.
Lona Biotherapeutics Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lona Biotherapeutics Ltd.'s valuation, stock price, and market status.